Skeletal muscle represents the largest organ mass in the body. It also represents the largest reserve of body protein. It is well established that advancing age is associated with a decline in skeletal muscle mass. However, it is not clear whether this decreased muscle mass is a result of aging per se, a chronic reduced level of physical activity which accompanies senescence, increased myofibrillar protein turnover, nutritional inadequacies, or the onset of disease processes. Our laboratory has demonstrated that eccentric exercise (a component of all exercise) causes muscle damage which results in a prolonged increase in the rate of protein degradation. Our data implicate the exercise-induced increase in circulating interleukin-1 and prolonged increase in skeletal muscle interleukin-1B as a mediator of these changes. In addition, we have demonstrated that older subjects experience more muscle damage and increased rates of myofibrillar protein degradation when compared to young subjects. However, the mechanisms for changes in muscle protein turnover following exercise are not well understood. The proposed studies will for the first time examine the effects of eccentric exercise on ubiquitin- mediated muscle protein degradation and the fractional rate of muscle protein synthesis in the elderly. We will use eccentric exercise to stimulate changes in muscle metabolism in older men and women. Specific mediators of proteolysis will be quantified with immunohistochemical techniques.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG000599-17
Application #
3745513
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
17
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02215
Elahi, Dariush; Ruff, Dennis A; Carlson, Olga D et al. (2016) Does GLP-1 suppress its own basal secretion? Endocr Res 41:16-20
Elahi, Dariush; Angeli, Franca S; Vakilipour, Amin et al. (2014) GLP-1(32-36)amide, a novel pentapeptide cleavage product of GLP-1, modulates whole body glucose metabolism in dogs. Peptides 59:20-4
Ahmed, Sofia B; Bentley-Lewis, Rhonda; Hollenberg, Norman K et al. (2009) A comparison of prediction equations for estimating glomerular filtration rate in pregnancy. Hypertens Pregnancy 28:243-55
Abu-Hamdah, Rania; Rabiee, Atoosa; Meneilly, Graydon S et al. (2009) Clinical review: The extrapancreatic effects of glucagon-like peptide-1 and related peptides. J Clin Endocrinol Metab 94:1843-52
Moore, T J; Rich, G; McKnight, J A et al. (1996) Salt sensitivity of hypertension and responses to angiotensin converting enzyme inhibition with benazepril. Am J Hypertens 9:54-60
Hollenberg, N K; Moore, T J (1994) Age and the renal blood supply: renal vascular responses to angiotensin converting enzyme inhibition in healthy humans. J Am Geriatr Soc 42:805-8
Allan, D R; McKnight, J A; Kifor, I et al. (1994) Converting enzyme inhibition and renal tissue angiotensin II in the rat. Hypertension 24:516-22
Bauer, K A; Kass, B L; ten Cate, H et al. (1990) Factor IX is activated in vivo by the tissue factor mechanism. Blood 76:731-6
Lee, J K; Gordon, P R; Stall, G M et al. (1989) Phenolic and tyrosyl ring iodothyronine deiodination by the Caco-2 human colon carcinoma cell line. Metabolism 38:1154-61
Bauer, K A; Weiss, L M; Sparrow, D et al. (1987) Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study. J Clin Invest 80:1527-34